Scrip Helps its Subscribers Achieve Commercial Pharma Success

With the most trusted and comprehensive source for global commercial news and critical insights for the pharmaceutical industry.

By focusing on the strategic implications of global pharma news, Scrip supports timely and tactical decision making throughout the entire drug discovery, development, and product life cycle value chain. Scrip helps accelerate time to market, realize greater cost savings, and stay ahead of the competition.

From biotech start-ups to multinational pharma giants, Scrip provides critical intelligence on the latest licensing opportunities, partnership deals, R&D activity, company developments and market access insights.

Scrip offers a variety of content and channels through which you can reach its subscribers.